The Genetics of Response to and Side Effects of Lithium Treatment in Bipolar Disorder: Future Research Perspectives

Although the mood stabilizer lithium is a first-line treatment in bipolar disorder, a substantial number of patients do not benefit from it and experience side effects. No clinical tool is available for predicting lithium response or the occurrence of side effects in everyday clinical practice. Mult...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Frontiers in pharmacology Jg. 12; S. 638882
Hauptverfasser:	Senner, Fanny, Kohshour, Mojtaba Oraki, Abdalla, Safa, Papiol, Sergi, Schulze, Thomas G.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Switzerland Frontiers Media S.A 25.03.2021
Schlagworte:	bipolar disorder candidate-gene association studies GWAS linkage and segregation studies lithium pharmacogenetics Pharmacology lithium side effect bipolar disorder GWAS treatment response candidate-gene association studies linkage and segregation studies pharmacogenetics
ISSN:	1663-9812, 1663-9812
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!